Nurse Practitioner in Jamestown, CA Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Gina M Valente-moore, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 18144 Seco St, Jamestown, CA 95327 Phone: 209-984-4820 Fax: 209-984-4825 |
Ann Radford, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 18144 Seco St, Jamestown, CA 95327 Phone: 209-984-4820 Fax: 209-984-4825 |
Mrs. Melissa Ann Ronneburg, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 18144 Seco St, Jamestown, CA 95327 Phone: 209-984-4820 Fax: 209-984-4825 |
News Archive
Study examines potential benefits of low fat diet on management of MS
People with multiple sclerosis who for one year followed a plant-based diet very low in saturated fat had much less MS-related fatigue at the end of that year - and significantly less fatigue than a control group of people with MS who didn't follow the diet, according to an Oregon Health & Science University study being presented today at the American Academy of Neurology's annual meeting in Philadelphia, Pa.
Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest
Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.
Length of residence in the U.S. increases risk of PTB among Hispanic women
The longer a Hispanic woman lives in the United States, the higher her risk of preterm birth (PTB), with nearly half of PTBs among Hispanic women occurring in those who were born in the U.S.
New cakes and frostings may someday contain less fat and calories
Delicious new cakes and frostings may someday contain less fat and fewer calories, thanks to work by Agricultural Research Service (ARS) scientists such as Mukti Singh. She's based at the ARS National Center for Agricultural Utilization Research (NCAUR) in Peoria, Ill.
Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
› Verified 1 days ago